Cencora OUTPH Insights

  1. Enhancing The Biosimilar Review Process 8/12/2025

    The biosimilar market is projected to reach over $100 billion in the next five years. Learn how to navigate the expanding landscape and overcome challenges in accessing key clinical information.

  2. How PIE Streamlines Biopharma And Payer Communication 8/12/2025

    Navigating pre-approval information exchange (PIE) with healthcare decision-makers is essential for market success. Learn what information can be shared and the best strategies for communication.

  3. Advancing Drug Safety: The Synergy Of Regulatory Affairs And Pharmacovigilance 7/14/2025

    Explore how pharmacovigilance and regulatory affairs teams work together throughout a product's lifecycle to monitor risks and keep vital safety information updated.

  4. CDISC + TMF Europe Interchange 2025: 5 Key Takeaways 7/14/2025

    The CDISC + TMF Europe Interchange showcased critical insights for TMF professionals. Learn about essential collaboration, the impact of AI, and the continued drive for standardization in clinical trials.

  5. Creating A Compliant And Scalable CGT Logistics Launch Plan 6/12/2025

    As cell and gene therapies advance to commercialization, biopharma companies face immense logistical hurdles. A customized, end-to-end strategy is crucial for ensuring product integrity and market success.